Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis

• Published in: Amyotrophic lateral sclerosis and frontotemporal degeneration Vol. 21; no. 7-8; pp. 502 - 508
• Main Authors: Liu, Jiao, Luo, Xiaoyue, Chen, Xueping, Shang, Huifang
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 01-10-2020
• Subjects: Amyotrophic lateral sclerosis; meta-analysis; overall mortality; serum creatinine; meta-analysis; Amyotrophic lateral sclerosis; overall mortality; serum creatinine
• ISSN: 2167-8421; 2167-9223
• DOI: 10.1080/21678421.2020.1774610

Serum creatinine (Cr) is a biosynthetic product of creatine phosphate metabolism in muscles and is closely related to total muscle mass, but it is not easily affected by diet. Several studies have tried to explore the role of serum Cr levels in amyotrophic lateral sclerosis (ALS), but the results were inconsistent. Therefore, our study aims to explore the differences of serum Cr levels between ALS patients and controls and whether serum Cr at baseline is an independent predictor of survival. Methods: We searched all the related studies that probed into the association between Serum Cr levels and ALS based on PubMed, EMBASE and Cochrane library from October 1952 to February 2019. The quality of the included studies was evaluated by using Newcastle-Ottawa Scale (NOS), and all the statistical analysis of this meta-analysis was performed by Stata version 12.0. Results: Eight studies with a total of 11377 ALS patients and 937 controls were included. Among them, five studies indicated that ALS patients had lower serum Cr levels (SMD = −0.78, 95%CI [−0.97, −0.60]) compared to controls, and three studies showed that higher serum Cr levels in ALS patients were related to lower overall mortality (HR 0.89, 95%CI [0.80, 0.99]). Conclusion: The levels of serum Cr in ALS patients are significantly lower than those in controls, and they are inversely related to overall mortality in ALS patients. Therefore, the serum Cr, an easily accessible serological factor, may serve as a prognostic biomarker.